Artículo Destacado en trastornos del movimiento

Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders

Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB.

Cell Mol Neurobiol. 2022 Oct;42(7):2075-2095. doi: 10.1007/s10571-021-01093-4. Epub 2021 May 1.

Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective

Su LD, Wang N, Han J, Shen Y.

Neuroscientist. 2022 Oct;28(5):453-468. doi: 10.1177/10738584211021018. Epub 2021 Jun 4.

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Oikonomou P, Jost WH.

J Neural Transm (Vienna). 2022 Oct;129(10):1247-1256. doi: 10.1007/s00702-022-02529-x. Epub 2022 Jul 20.

CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics

Sen T, Thummer RP.

Neurotox Res. 2022 Oct;40(5):1597-1623. doi: 10.1007/s12640-022-00564-w. Epub 2022 Aug 31.

Endosomal recycling defects link Huntington's disease with McLeod syndrome

Marsan E, Huang EJ.

J Cell Biol. 2022 Oct 3;221(10):e202208164. doi: 10.1083/jcb.202208164. Epub 2022 Sep 16.

Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases

Bild W, Vasincu A, Rusu RN, Ababei DC, Stana AB, Stanciu GD, Savu B, Bild V.

Biomolecules. 2022 Oct 6;12(10):1429. doi: 10.3390/biom12101429.

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders

Baier A, Szyszka R.

Front Mol Biosci. 2022 Oct 6;9:916063. doi: 10.3389/fmolb.2022.916063. eCollection 2022.

Neuroprotective potential of Moringa oleifera mediated by NF-kB/Nrf2/HO-1 signaling pathway: A review

Mundkar M, Bijalwan A, Soni D, Kumar P.

J Food Biochem. 2022 Oct 7:e14451. doi: 10.1111/jfbc.14451. Online ahead of print.

Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders

Reddy DS, Abeygunaratne HN.

Int J Mol Sci. 2022 Oct 3;23(19):11734. doi: 10.3390/ijms231911734.

Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review

Wang Q, Xue H, Yue Y, Hao S, Huang SH, Zhang Z.

Front Mol Neurosci. 2022 Oct 4;15:1014251. doi: 10.3389/fnmol.2022.1014251. eCollection 2022.

Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases

Zhang L, Liu Y, Lu Y, Wang G.

Biochem Pharmacol. 2022 Oct 12;206:115295. doi: 10.1016/j.bcp.2022.115295. Online ahead of print.

The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases

Liu H, Xu S, Wang C, Deng Y, Xu B, Yang T, Sun J, Liu W.

Neuroscience. 2022 Oct 3:S0306-4522(22)00491-2. doi: 10.1016/j.neuroscience.2022.09.021. Online ahead of print.

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2

Egorova PA, Bezprozvanny IB.

Cerebellum. 2022 Oct;21(5):742-749. doi: 10.1007/s12311-021-01349-1. Epub 2022 Jan 3.